Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
74
OPXS Quote, Financials, Valuation and Earnings
Last price:
$12.10
Seasonality move
:
-1.58%
Day range:
$12.00 - $14.00
52-week range:
$5.36 - $14.60
Dividend yield:
0%
P/E ratio:
17.42x
P/S ratio:
2.28x
P/B ratio:
3.96x
Volume:
112.4K
Avg. volume:
91.9K
1-year change:
51.16%
Market cap:
$85.5M
Revenue:
$34M
EPS (TTM):
$0.71
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Optex Systems Holdings has -- downside to fair value with a price target of -- per share.
OPXS vs. S&P 500
-
Over the past 5 trading days, Optex Systems Holdings has overperformed the S&P 500 by 1.83% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Optex Systems Holdings does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Optex Systems Holdings has grown year-over-year revenues for 9 quarters straight. In the most recent quarter Optex Systems Holdings reported revenues of $10.7M.
Earnings Growth
-
Optex Systems Holdings has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Optex Systems Holdings reported earnings per share of $0.26.
Enterprise value:
81.9M
EV / Invested capital:
--
Price / LTM sales:
2.28x
EV / EBIT:
13.51x
EV / Revenue:
2.19x
PEG ratio (5yr expected):
0.48x
EV / Free cash flow:
21.62x
Price / Operating cash flow:
22.50x
Enterprise value / EBITDA:
12.42x
Gross Profit (TTM):
$10.8M
Return On Assets:
19.32%
Net Income Margin (TTM):
13.06%
Return On Equity:
25.91%
Return On Invested Capital:
25.24%
Operating Margin:
20.85%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $23.3M | $30.7M | $37.4M | $8.5M | $10.7M | |
| Gross Profit | $5.6M | $8.6M | $10.8M | $2.6M | $3.4M | |
| Operating Income | $2.2M | $4.4M | $6.1M | $1.4M | $2.2M | |
| EBITDA | $2.5M | $4.8M | $6.6M | $1.5M | $2.4M | |
| Diluted EPS | $0.21 | $0.52 | $0.71 | $0.16 | $0.26 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $15.1M | $15.5M | $15M | $18.3M | $22.3M | |
| Total Assets | $21.1M | $21.2M | $19.9M | $23.8M | $27.5M | |
| Current Liabilities | $3.6M | $2.8M | $3.7M | $4.7M | $4.4M | |
| Total Liabilities | $7.3M | $5.8M | $7.2M | $7.3M | $5.9M | |
| Total Equity | $13.8M | $15.4M | $12.7M | $16.5M | $21.6M | |
| Total Debt | $377K | -- | $1M | $500K | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$359K | $1.7M | $4.8M | -$1.3M | $1.2M | |
| Cash From Investing | -$285K | -$1.4M | -$997K | -$1.1M | -$144K | |
| Cash From Financing | -$3.6M | -$671K | -$581K | $363K | -- | |
| Free Cash Flow | -$644K | $316K | $3.8M | -$2.4M | $1M | |
OPXS
Sector
Market Cap
$85.5M
$611.3M
Price % of 52-Week High
84.69%
81.21%
Dividend Yield
0%
0%
Shareholder Yield
--
2.28%
1-Year Price Total Return
51.16%
-1.12%
Beta (5-Year)
0.335
0.761
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$12.66
200-day SMA
Buy
Level
$7.78
Bollinger Bands (100)
Buy
Level
5.41 - 10.21
Chaikin Money Flow
Buy
Level
46.6K
20-day SMA
Buy
Level
$11.77
Relative Strength Index (RSI14)
Buy
Level
57.78
ADX Line
Buy
Level
23
Williams %R
Neutral
Level
-58.354
50-day SMA
Buy
Level
$9.79
MACD (12, 26)
Buy
Level
3.56
25-day Aroon Oscillator
Buy
Level
80
On Balance Volume
Sell
Level
-5.8K
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (7.2104)
Buy
CA Score
(Annual)
Level (1.9477)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (7)
Buy
Ohlson Score
Level (-2.1166)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Optex Systems Holdings Inc manufactures optical sighting systems and assemblies for the U.S. Department of Defense, foreign military applications, and commercial markets. Its products are installed on a variety of United States military land vehicles, such as the Abrams and Bradley fighting vehicles, and light armored and security vehicles, and have been selected for installation on the Stryker family of vehicles. The company's operating segment includes Optex Systems Richardson and Applied Optics Center Dallas and others. It generates maximum revenue from the Optex Systems Richardson segment. Some of its products include M17 Day/Thermal Periscope; DDAN / M36 Sights; Laser Protected Periscopes; Muzzle Reference Sensor and others.
Stock Forecast FAQ
In the current month, OPXS has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The OPXS average analyst price target in the past 3 months is --.
-
Where Will Optex Systems Holdings Stock Be In 1 Year?
According to analysts, the consensus estimate is that Optex Systems Holdings share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Optex Systems Holdings?
Analysts are divided on their view about Optex Systems Holdings share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Optex Systems Holdings is a Sell and believe this share price will rise from its current level to --.
-
What Is Optex Systems Holdings's Price Target?
The price target for Optex Systems Holdings over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is OPXS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Optex Systems Holdings is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of OPXS?
You can purchase shares of Optex Systems Holdings via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Optex Systems Holdings shares.
-
What Is The Optex Systems Holdings Share Price Today?
Optex Systems Holdings was last trading at $12.10 per share. This represents the most recent stock quote for Optex Systems Holdings. Yesterday, Optex Systems Holdings closed at $12.37 per share.
-
How To Buy Optex Systems Holdings Stock Online?
In order to purchase Optex Systems Holdings stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 1.01% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 10.79% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 5.29% over the past day.
